Deutsche Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.78M | Sell |
25,273
-115,013
| -82% | -$20.1M | ﹤0.01% | 1315 |
|
|
2025
Q4 | $23.8M | Buy |
140,286
+124,864
| +810% | +$19.1M | 0.01% | 827 |
|
|
2025
Q3 | $2.03M | Buy |
15,422
+801
| +5% | +$96.1K | ﹤0.01% | 1762 |
|
|
2025
Q2 | $1.55M | Buy |
14,621
+205
| +1% | +$22.3K | ﹤0.01% | 1851 |
|
|
2025
Q1 | $1.79M | Sell |
14,416
-1,596
| -10% | -$208K | ﹤0.01% | 1828 |
|
|
2024
Q4 | $1.97M | Buy |
16,012
+609
| +4% | +$71.8K | ﹤0.01% | 1862 |
|
|
2024
Q3 | $1.72M | Sell |
15,403
-4,401
| -22% | -$482K | ﹤0.01% | 1849 |
|
|
2024
Q2 | $2.11M | Sell |
19,804
-127,860
| -87% | -$14.1M | ﹤0.01% | 1610 |
|
|
2024
Q1 | $17.8M | Sell |
147,664
-15,265
| -9% | -$1.87M | 0.01% | 848 |
|
|
2023
Q4 | $20M | Buy |
162,929
+32,410
| +25% | +$4.04M | 0.01% | 802 |
|
|
2023
Q3 | $16.9M | Sell |
130,519
-24,602
| -16% | -$3.28M | 0.01% | 746 |
|
|
2023
Q2 | $19.2M | Sell |
155,121
-13,805
| -8% | -$1.86M | 0.01% | 795 |
|
|
2023
Q1 | $24.7M | Sell |
168,926
-10,788
| -6% | -$1.6M | 0.01% | 702 |
|
|
2022
Q4 | $28.6M | Sell |
179,714
-2,845
| -2% | -$417K | 0.02% | 665 |
|
|
2022
Q3 | $24.3M | Buy |
182,559
+60,451
| +50% | +$9.19M | 0.01% | 707 |
|
|
2022
Q2 | $19.1M | Sell |
122,108
-1,567
| -1% | -$241K | 0.01% | 795 |
|
|
2022
Q1 | $19.3M | Buy |
123,675
+21,613
| +21% | +$3.14M | 0.01% | 845 |
|
|
2021
Q4 | $13M | Sell |
102,062
-5,866
| -5% | -$771K | 0.01% | 1010 |
|
|
2021
Q3 | $14.1M | Buy |
107,928
+3,722
| +4% | +$562K | 0.01% | 1016 |
|
|
2021
Q2 | $18.5M | Sell |
104,206
-19,294
| -16% | -$3.34M | 0.01% | 934 |
|
|
2021
Q1 | $20.3M | Buy |
123,500
+25,650
| +26% | +$4.22M | 0.01% | 898 |
|
|
2020
Q4 | $16.1M | Buy |
97,850
+2,492
| +3% | +$371K | 0.01% | 859 |
|
|
2020
Q3 | $13.6M | Sell |
95,358
-12,889
| -12% | -$1.6M | 0.01% | 839 |
|
|
2020
Q2 | $11.9M | Buy |
108,247
+24,963
| +30% | +$2.76M | 0.01% | 897 |
|
|
2020
Q1 | $8.3M | Sell |
83,284
-36,097
| -30% | -$4.67M | 0.01% | 985 |
|
|
2019
Q4 | $17.8M | Buy |
119,381
+26,395
| +28% | +$3.59M | 0.01% | 830 |
|
|
2019
Q3 | $11.9M | Buy |
92,986
+2,444
| +3% | +$328K | 0.01% | 999 |
|
|
2019
Q2 | $12.9M | Sell |
90,542
-105,479
| -54% | -$14.2M | 0.01% | 1203 |
|
|
2019
Q1 | $28M | Buy |
196,021
+73,477
| +60% | +$9.58M | 0.02% | 825 |
|
|
2018
Q4 | $15.2M | Sell |
122,544
-95,446
| -44% | -$14.2M | 0.01% | 1047 |
|
|
2018
Q3 | $36.6M | Buy |
217,990
+33,132
| +18% | +$5.7M | 0.02% | 795 |
|
|
2018
Q2 | $31.8M | Sell |
184,858
-8,198
| -4% | -$1.34M | 0.02% | 898 |
|
|
2018
Q1 | $29.1M | Sell |
193,056
-85,711
| -31% | -$12.6M | 0.01% | 891 |
|
|
2017
Q4 | $37.5M | Buy |
278,767
+42,333
| +18% | +$5.87M | 0.02% | 660 |
|
|
2017
Q3 | $34.6M | Sell |
236,434
-83,965
| -26% | -$12.7M | 0.02% | 708 |
|
|
2017
Q2 | $49.8M | Buy |
320,399
+117,673
| +58% | +$18M | 0.04% | 527 |
|
|
2017
Q1 | $29.4M | Sell |
202,726
-139,215
| -41% | -$18.1M | 0.02% | 709 |
|
|
2016
Q4 | $37.3M | Buy |
341,941
+75,928
| +29% | +$8.46M | 0.03% | 582 |
|
|
2016
Q3 | $32.3M | Sell |
266,013
-144,727
| -35% | -$19.5M | 0.02% | 693 |
|
|
2016
Q2 | $58M | Buy |
410,740
+143,569
| +54% | +$21.2M | 0.04% | 463 |
|
|
2016
Q1 | $34.9M | Buy |
267,171
+63,566
| +31% | +$7.91M | 0.03% | 642 |
|
|
2015
Q4 | $28.6M | Sell |
203,605
-8,309
| -4% | -$1.15M | 0.02% | 774 |
|
|
2015
Q3 | $28.1M | Sell |
211,914
-39,896
| -16% | -$6.87M | 0.02% | 714 |
|
|
2015
Q2 | $44.3M | Buy |
251,810
+61,131
| +32% | +$11M | 0.03% | 580 |
|
|
2015
Q1 | $32.9M | Sell |
190,679
-40,599
| -18% | -$6.97M | 0.02% | 705 |
|
|
2014
Q4 | $37.9M | Buy |
231,278
+70,044
| +43% | +$11.6M | 0.02% | 691 |
|
|
2014
Q3 | $25.9M | Buy |
161,234
+17,711
| +12% | +$2.72M | 0.02% | 826 |
|
|
2014
Q2 | $21.1M | Sell |
143,523
-10,358
| -7% | -$1.44M | 0.01% | 907 |
|
|
2014
Q1 | $21.3M | Sell |
153,881
-13,126
| -8% | -$1.98M | 0.02% | 891 |
|
|
2013
Q4 | $21.1M | Buy |
167,007
+46,800
| +39% | +$4.84M | 0.02% | 890 |
|
|
2013
Q3 | $11.1M | Sell |
120,207
-124,767
| -51% | -$10.1M | 0.01% | 1258 |
|
|
2013
Q2 | $16.8M | Buy |
+244,974
| New | +$15M | 0.01% | 942 |
|
Other funds holding JAZZ
VPM
VCM
EC
Deutsche Bank's JAZZ Position: Q1 2026 in Review
Deutsche Bank reduced its Jazz Pharmaceuticals (JAZZ) stake by 82% in Q1 2026, selling an estimated $20.1M and leaving 25,273 shares worth $4.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1315.
Deutsche Bank first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $58M in Q2 2016. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Deutsche Bank held 25,273 shares of Jazz Pharmaceuticals worth $4.78M as of Q1 2026.
- Deutsche Bank sold 115,013 Jazz Pharmaceuticals shares in Q1 2026, an estimated $20.1M.
- Jazz Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1315 holding.
- Deutsche Bank first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Jazz Pharmaceuticals position peaked at $58M in Q2 2016.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.